Want to see IN:NEOGEN full AI Analyst Report?
NEOGEN Stock Chart & Stats
₹2063.35
₹1.30(0.06%)
At close: 4:00 PM EDT
₹2063.35
₹1.30(0.06%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹2,482.70
Previous CloseN/A
Volume149.32K
Average Volume (3M)8.34K
Market Cap
₹58.61B
Enterprise Value₹43.23K
Total Cash (Recent Filing)₹49.50M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)162.0
Beta1.54
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.05%
Share Statistics
EPS (TTM)13.25
Shares Outstanding27,381,674
10 Day Avg. Volume5,630
30 Day Avg. Volume8,341
Financial Highlights & Ratios
PEG Ratio-5.85
Price to Book (P/B)3.59
Price to Sales (P/S)3.40
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.02
Revenue Forecast (FY)₹12.58B
Bulls Say, Bears Say
Bulls Say
Strong Multi-Year Revenue GrowthSustained revenue expansion indicates growing market reach and customer demand. Continued top-line growth provides a foundation for operating leverage if Neogen can improve product mix, pricing and capacity utilization.
Specialty Chemical Business ModelSpecialty intermediates are produced to customer specifications, while qualification and consistency requirements can support repeat B2B relationships. This creates greater customer stickiness than purely commoditized chemical products.
Lithium-Based Product ExpansionExpansion into lithium chemicals broadens Neogen beyond brominated intermediates and provides exposure to battery-material supply chains. If customer approvals and capacity ramp-up progress, this can add a structural growth avenue.
Bears Say
Sharp Margin CompressionThe steep decline in gross and net margins signals weaker pricing, adverse product mix or higher input costs. Persistently lower profitability would reduce earnings resilience and make future growth less valuable.
Material Increase In LeverageThe rapid debt build materially increases financing and execution risk, particularly alongside weaker returns. Higher interest and repayment obligations can constrain investment flexibility and amplify the impact of operational setbacks.
Negative Cash GenerationNegative operating and free cash flow indicate that reported growth is not currently converting into internal funding. Continued cash burn could increase dependence on borrowing or external capital, especially after the debt increase.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹2482.70 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹58.61B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 60 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on Jul 24, 2026. The company reported ₹6.2 earnings per share for the quarter, beating the consensus estimate of ₹5.14 by ₹1.06.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Overvalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.05%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 27,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹6.2 in its last earnings report, beating expectations of ₹5.14. Following the earnings report the stock price went down -1.128%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited, founded in Thane, India, in 1989, is engaged in the manufacturing and supply of an extensive array of specialized chemical products. The company's comprehensive portfolio encompasses numerous organo-bromine compounds, including alkyl bromides, dibromoalkanes, bromo chloro alkanes, various bromine derivatives (of organoacids, esters, aromatics, and cyclics), and specialty bromo-fluoro derivatives. Additionally, Neogen offers specialty chloro compounds, unsaturated and bromo-hydroxy derivatives, inorganic bromine compounds, lithium salts, Grignard reagents, and advanced intermediates. Beyond its product range, the firm also provides custom synthesis and contract manufacturing services. Neogen's offerings cater to diverse industrial sectors such as pharmaceuticals, agrochemicals, engineering, flavors and fragrances, electronic chemicals, refrigeration, construction, specialty polymers, and heating, ventilation, and air conditioning (HVAC). The company maintains an international presence, exporting its chemicals to 28 nations globally.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Balaji Amines Limited
―
Laxmi Organic Industries Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Vishnu Chemicals Limited
―